Intercept Pharmaceuticals, Inc.

GOLDMAN SACHS GROUP INC

Report date

9/30/2023

Quarter

2023 Q3

Filed

5/15/2024

Shares

1,019,073

Value ($000)

18,894

Weight

0.0%

2014 Q1 - 2023 Q3 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	5/15/2024	18,894	0.0%	1,019,073	9/30/2023
2023 Q2	5/14/2024	3,289	0.0%	297,420	6/30/2023
2023 Q1	5/14/2024	10,248	0.0%	763,034	3/31/2023
2022 Q4	5/14/2024	6,806	0.0%	550,239	12/31/2022
2022 Q3	5/14/2024	5,196	0.0%	372,466	9/30/2022
2022 Q2	5/14/2024	5,076	0.0%	367,535	6/30/2022
2022 Q1	5/16/2022	7,792	0.0%	478,923	3/31/2022
2021 Q4	2/17/2022	7,068	0.0%	433,967	12/31/2021
2021 Q3	1/20/2022	4,433	0.0%	298,492	9/30/2021
2021 Q2	8/13/2021	7,943	0.0%	397,763	6/30/2021
2021 Q1	5/17/2021	11,445	0.0%	495,877	3/31/2021
2020 Q4	2/12/2021	24,734	0.0%	1,001,382	12/31/2020
2020 Q3	11/13/2020	26,879	0.0%	648,303	9/30/2020
2020 Q2	8/12/2020	20,065	0.0%	418,821	6/30/2020
2020 Q1	5/15/2020	16,193	0.0%	257,197	3/31/2020
2019 Q4	2/14/2020	18,977	0.0%	153,139	12/31/2019
2014 Q1	5/15/2014	3,190	0.0%	9,673	3/31/2014